glp-1 obesity drug news today oct 23 2025 Market GLP-1 Agonists Weight Loss Drugs
Description
Guidelines currently recommend organ-specific management of obesity-related complications
Starting today, eligible Medicare patients living with obesity can access Wegovy (semaglutide) injection and pill for a $50 monthly copay Wegovy offers...
Here's what you need to know and how to save 10%.
GLP-1 drugs like Ozempic have transformed weight management, but concerns around muscle loss, bone density, dampened desire, and dependency are growing
Learn how the new Wegovy pill compares to injections and what this means for your weight loss care.
